BioRestorative Therapies Inc (BRTX):企業の財務・戦略的SWOT分析

◆英語タイトル:BioRestorative Therapies Inc (BRTX) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH218080FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥66,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥99,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
BioRestorative Therapies Inc (BRT), formerly Stem Cell Assurance Inc is a developer of therapeutic products and medical therapies. The company performs stem cell programs which include brtxDISC and ThermoStem. brtxDISC,a lead therapeutic product, is designed to offer a non-surgical treatment for chronic lumbar disc diseases such as bulging and herniated discs. Its ThermoStem program develops brown fat stem cell-based therapy which is used for the treatment of type 2 diabetes, obesity, and other metabolic disorders. BRT provides identification and treatment of first stem cell population isolated from a particular brown fat depot in human. The company operates in the US. BRT is headquartered in Melville, New York, the US.

BioRestorative Therapies Inc Key Recent Developments

Apr 05,2021: BioRestorative Therapies Announces Appointment of Nickolay V. Kukekov, Ph.D to its Board of Directors
Nov 20,2020: BioRestorative Therapies emerges from Chapter 11 Reorganization

This comprehensive SWOT profile of BioRestorative Therapies Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of BioRestorative Therapies Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

BioRestorative Therapies Inc – Key Information
BioRestorative Therapies Inc – Overview
BioRestorative Therapies Inc – Key Employees
BioRestorative Therapies Inc – Key Employee Biographies
BioRestorative Therapies Inc – Key Operational Heads
BioRestorative Therapies Inc – Major Products and Services
BioRestorative Therapies Inc – History
BioRestorative Therapies Inc – Company Statement
BioRestorative Therapies Inc – Locations And Subsidiaries
BioRestorative Therapies Inc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

BioRestorative Therapies Inc – Business Description
BioRestorative Therapies Inc – Corporate Strategy
BioRestorative Therapies Inc – SWOT Analysis
SWOT Analysis – Overview
BioRestorative Therapies Inc – Strengths
BioRestorative Therapies Inc – Weaknesses
BioRestorative Therapies Inc – Opportunities
BioRestorative Therapies Inc – Threats
BioRestorative Therapies Inc – Key Competitors

Section 3 – Company Financial Performance Charts

BioRestorative Therapies Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

BioRestorative Therapies Inc, Key Information
BioRestorative Therapies Inc, Key Ratios
BioRestorative Therapies Inc, Share Data
BioRestorative Therapies Inc, Major Products and Services
BioRestorative Therapies Inc, History
BioRestorative Therapies Inc, Key Employees
BioRestorative Therapies Inc, Key Employee Biographies
BioRestorative Therapies Inc, Key Operational Heads
BioRestorative Therapies Inc, Other Locations
BioRestorative Therapies Inc, Subsidiaries

BioRestorative Therapies Inc, Key Competitors
BioRestorative Therapies Inc, SWOT Analysis
BioRestorative Therapies Inc, Ratios based on current share price
BioRestorative Therapies Inc, Annual Ratios
BioRestorative Therapies Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[BioRestorative Therapies Inc (BRTX):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Breko GmbH:企業の戦略・SWOT・財務分析
    Breko GmbH - Strategy, SWOT and Corporate Finance Report Summary Breko GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Heidelberger Druckmaschinen AG:企業の戦略・SWOT・財務分析
    Heidelberger Druckmaschinen AG - Strategy, SWOT and Corporate Finance Report Summary Heidelberger Druckmaschinen AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Kuwait And Middle East Financial Investment Company (K.S.C.P.) (KMEFIC):企業の財務・戦略的SWOT分析
    Kuwait And Middle East Financial Investment Company (K.S.C.P.) (KMEFIC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view …
  • Brown & Brown, Inc.:企業の戦略・SWOT・財務情報
    Brown & Brown, Inc. - Strategy, SWOT and Corporate Finance Report Summary Brown & Brown, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • NantKwest Inc (NK):製薬・医療:M&Aディール及び事業提携情報
    Summary NantKwest Inc (NantKwest), a subsidiary of NantWorks LLC, formerly Conkwest Inc, is a clinical-stage immunotherapy company that develops therapeutic treatments for cancer, infectious diseases, and inflammatory diseases. The company utilizes its immuno-oncology NK platform to destroy the tumo …
  • Oncolytics Biotech Inc (ONC)-製薬・医療分野:企業M&A・提携分析
    Summary Oncolytics Biotech Inc (Oncolytics) is a development stage biopharmaceutical company which focuses on the discovery and development of oncolytic viruses for the treatment of cancer. The company’s lead product, Reolysin, a formulation of the human reovirus, is at Phase II clinical trials indi …
  • Jiangsu Kanion Pharmaceutical Co Ltd (600557):製薬・医療:M&Aディール及び事業提携情報
    Summary Jiangsu Kanion Pharmaceutical Co Ltd (Jiangsu Kanion) is a developer, producer and marketer of concentrated drugs. The company offers products in the therapeutic areas of orthopedics, cardiovascular, gynecology, antitumor, anti-infective, and others. It also offers products for fever, headac …
  • NAPEC Inc. (NPC)-エネルギー分野:企業M&A・提携分析
    Summary NAPEC Inc. (NAPEC), formerly CVTech Group Inc., is an energy services company that provides construction and maintenance services. It builds and maintains electrical transmission and distribution systems, solar panel farms, and natural gas networks. The company installs gas-powered and elect …
  • UnitedHealth Group Inc (UNH):企業の財務・戦略的SWOT分析
    UnitedHealth Group Inc (UNH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • EnerDel Inc:企業の戦略的SWOT分析
    EnerDel Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Informa plc:企業の戦略・SWOT・財務分析
    Informa plc - Strategy, SWOT and Corporate Finance Report Summary Informa plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • The Johnny Rockets Group, Inc.:企業の戦略・SWOT・財務情報
    The Johnny Rockets Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary The Johnny Rockets Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Raytheon Co:企業のM&A・事業提携・投資動向
    Raytheon Co - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Raytheon Co Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • Japan Petroleum Exploration Co Ltd (1662):石油・ガス:M&Aディール及び事業提携情報
    Summary Japan Petroleum Exploration Co Ltd (JAPEX) is an oil and gas company that offers exploration, development, production, and sales of oil, natural gas, and other energy resources. The company’s services include acquisition of blocks, development, exploration, supplying, selling, and transporta …
  • KeyCorp (KEY)-エネルギー分野:企業M&A・提携分析
    Summary KeyCorp (KeyCorp) is a financial holding company that offers a range of retail and commercial banking, consumer finance, commercial mortgage and special servicing, commercial leasing, investment management, and investment banking products and services to individuals, corporate, and instituti …
  • Hiscox Ltd:戦略・SWOT・企業財務分析
    Hiscox Ltd - Strategy, SWOT and Corporate Finance Report Summary Hiscox Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Sonic Healthcare Limited:企業の戦略・SWOT・財務情報
    Sonic Healthcare Limited - Strategy, SWOT and Corporate Finance Report Summary Sonic Healthcare Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Adamis Pharmaceuticals Corp (ADMP)-製薬・医療分野:企業M&A・提携分析
    Summary Adamis Pharmaceuticals Corp (Adamis), formerly Cellegy Pharmaceuticals Inc is a biopharmaceutical company that offers therapies. The company develops and commercializes products in the therapeutic areas of allergy and respiratory diseases. Its pipeline product, epinephrine pre-filled syringe …
  • Eli Lilly and Company:企業のM&A・事業提携・投資動向
    Eli Lilly and Company - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Eli Lilly and Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Companhia Energetica de Minas Gerais – CEMIG:企業の戦略・SWOT・財務情報
    Companhia Energetica de Minas Gerais - CEMIG - Strategy, SWOT and Corporate Finance Report Summary Companhia Energetica de Minas Gerais - CEMIG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operati …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆